LXR Regulation of Brain Cholesterol: From Development to Disease

Skerrett, 2014, Nuclear receptors in neurodegenerative diseases, Neurobiol. Dis., 72, 104, 10.1016/j.nbd.2014.05.019 Romanoski, 2015, Exploiting genomics and natural genetic variation to decode macrophage enhancers, Trends Immunol., 36, 507, 10.1016/j.it.2015.07.006 Saijo, 2013, Regulation of microglia activation and deactivation by nuclear receptors, Glia, 61, 104, 10.1002/glia.22423 Vitali, 2014, HDL and cholesterol handling in the brain, Cardiovasc. Res., 103, 405, 10.1093/cvr/cvu148 Zhang, 2012, Feedback regulation of cholesterol uptake by the LXR–IDOL–LDLR axis, Arterioscler. Thromb. Vasc. Biol., 32, 2541, 10.1161/ATVBAHA.112.250571 Gabbi, 2014, Action mechanisms of liver X receptors, Biochem. Biophys. Res. Commun., 446, 647, 10.1016/j.bbrc.2013.11.077 Matsuda, 2013, 24(S)-Hydroxycholesterol is actively eliminated from neuronal cells by ABCA1, J. Neurochem., 126, 93, 10.1111/jnc.12275 Sun, 2015, 24(S)-Hydroxycholesterol as a modulator of neuronal signaling and survival, Neuroscientist, 22, 132, 10.1177/1073858414568122 Okabe, 2013, Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death, Redox Biol., 2, 28, 10.1016/j.redox.2013.11.007 Moutinho, 2015, Cholesterol 24S-hydroxylase overexpression inhibits the liver X Receptor (LXR) pathway by activating small guanosine triphosphate-binding proteins (sGTPases) in neuronal cells, Mol. Neurobiol., 51, 1489, 10.1007/s12035-014-8828-0 Noguchi, 2014, Diverse functions of 24(S)-hydroxycholesterol in the brain, Biochem. Biophys. Res. Commun., 446, 692, 10.1016/j.bbrc.2014.02.010 Noguchi, 2015, New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death, Free Radic. Biol. Med., 87, 366, 10.1016/j.freeradbiomed.2015.06.036 Paul, 2013, The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors, J. Neurosci., 33, 17290, 10.1523/JNEUROSCI.2619-13.2013 Linsenbardt, 2014, Different oxysterols have opposing actions at N-methyl-D-aspartate receptors, Neuropharmacology, 85, 232, 10.1016/j.neuropharm.2014.05.027 Luu, 2016, Oxysterols: old tale, new twists, Annu. Rev. Pharmacol. Toxicol., 56, 447, 10.1146/annurev-pharmtox-010715-103233 Mateos, 2011, Side chain-oxidized oxysterols regulate the brain renin–angiotensin system through a liver X receptor-dependent mechanism, J. Biol. Chem., 286, 25574, 10.1074/jbc.M111.236877 Zhang, 2015, 27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain, Neuroscience, 300, 163, 10.1016/j.neuroscience.2015.05.022 Heverin, 2015, 27-Hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice, Behav. Brain Res., 278, 356, 10.1016/j.bbr.2014.10.018 Prasanthi, 2009, Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on β-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells, Mol. Neurodegener., 4, 1, 10.1186/1750-1326-4-1 Gamba, 2014, Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine, Aging Cell, 13, 561, 10.1111/acel.12206 Scott Kim, 2009, Impact of 27-hydroxycholesterol on amyloid-β peptide production and ATP-binding cassette transporter expression in primary human neurons, J. Alzheimers Dis., 16, 121, 10.3233/JAD-2009-0944 Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263 Lane-Donovan, 2014, More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration, Neuron, 83, 771, 10.1016/j.neuron.2014.08.005 Zelcer, 2009, LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor, Science, 325, 100, 10.1126/science.1168974 Sorrentino, 2011, Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible degrader of the LDLR (IDOL), J. Biol. Chem., 286, 30190, 10.1074/jbc.M111.249557 Sorrentino, 2013, The LXR–IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation, J. Lipid Res., 54, 2174, 10.1194/jlr.M037713 Hong, 2010, The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and apoER2, J. Biol. Chem., 285, 19720, 10.1074/jbc.M110.123729 Hong, 2014, The LXR–Idol axis differentially regulates plasma LDL levels in primates and mice, Cell Metab., 20, 910, 10.1016/j.cmet.2014.10.001 Do, 2013, Reciprocal regulation of very low density lipoprotein receptors (VLDLRs) in neurons by brain-derived neurotrophic factor (BDNF) and Reelin: involvement of the E3 ligase Mylip/Idol, J. Biol. Chem., 288, 29613, 10.1074/jbc.M113.500967 Choi, 2015, The E3 ubiquitin ligase Idol controls brain LDL receptor expression, apoE clearance, and Aβ amyloidosis, Sci. Transl. Med., 7, 314ra184, 10.1126/scitranslmed.aad1904 Nelson, 2016, The deubiquitylase USP2 regulates the LDLR pathway by counteracting the E3–ubiquitin ligase IDOL, Circ. Res., 118, 410, 10.1161/CIRCRESAHA.115.307298 Nelson, 2016, Deubiquitylase inhibition reveals liver X receptor-independent transcriptional regulation of the E3 ubiquitin ligase IDOL and lipoprotein uptake, J. Biol. Chem., 291, 4813, 10.1074/jbc.M115.698688 Fan, 2008, Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons, Proc. Natl Acad. Sci. U.S.A., 105, 13445, 10.1073/pnas.0806974105 Xing, 2010, Liver X receptor agonist treatment promotes the migration of granule neurons during cerebellar development, J. Neurochem., 115, 1486, 10.1111/j.1471-4159.2010.07053.x Pinto, 2016, Lxr regulates lipid metabolic and visual perception pathways during zebrafish development, Mol. Cell. Endocrinol., 419, 29, 10.1016/j.mce.2015.09.030 Wang, 2002, Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration, Proc. Natl. Acad. Sci. U.S.A., 99, 13878, 10.1073/pnas.172510899 Andersson, 2005, Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice, Proc. Natl Acad. Sci. U.S.A., 102, 3857, 10.1073/pnas.0500634102 Kim, 2008, Liver X receptor beta (LXRβ): a link between β-sitosterol and amyotrophic lateral sclerosis–Parkinson's dementia, Proc. Natl Acad. Sci. U.S.A., 105, 2094, 10.1073/pnas.0711599105 Sacchetti, 2009, Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells, Cell Stem Cell, 5, 409, 10.1016/j.stem.2009.08.019 Theofilopoulos, 2013, Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis, Nat. Chem. Biol., 9, 126, 10.1038/nchembio.1156 Theofilopoulos, 2014, Cholestenoic acids regulate motor neuron survival via liver X receptors, J. Clin. Invest., 124, 4829, 10.1172/JCI68506 Makoukji, 2011, Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols, J. Neurosci., 31, 9620, 10.1523/JNEUROSCI.0761-11.2011 Meffre, 2015, Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum, Proc. Natl Acad. Sci. U.S.A., 112, 7587, 10.1073/pnas.1424951112 Xu, 2014, Liver X receptor β is essential for the differentiation of radial glial cells to oligodendrocytes in the dorsal cortex, Mol. Psychiatry, 19, 947, 10.1038/mp.2014.60 Nelissen, 2012, Liver X receptors regulate cholesterol homeostasis in oligodendrocytes, J. Neurosci. Res., 90, 60, 10.1002/jnr.22743 Kruczek, 2015, Activation of nuclear receptors RAR, RXR, and LXR does not reduce cuprizone-induced demyelination in mice, Nucl. Recept. Res., 2, 101163, 10.11131/2015/101163 Shackleford, 2013, Differential regulation of Wnt/beta-catenin signaling by liver X RECEPTORS in Schwann cells and oligodendrocytes, Biochem. Pharmacol., 86, 106, 10.1016/j.bcp.2013.02.036 Gabbi, 2008, Pancreatic exocrine insufficiency in LXRβ−/− mice is associated with a reduction in aquaporin-1 expression, Proc. Natl Acad. Sci. U.S.A., 105, 15052, 10.1073/pnas.0808097105 Gabbi, 2012, Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β, Proc. Natl Acad. Sci. U.S.A., 109, 3030, 10.1073/pnas.1200588109 Dai, 2015, Liver X receptors regulate cerebrospinal fluid production, Mol. Psychiatry. Spann, 2013, Sterols and oxysterols in immune cell function, Nat. Immunol., 14, 893, 10.1038/ni.2681 Saijo, 2011, Microglial cell origin and phenotypes in health and disease, Nat. Rev. Immunol., 11, 775, 10.1038/nri3086 Cordle, 2005, Mechanisms of statin-mediated inhibition of small G-protein function, J. Biol. Chem., 280, 34202, 10.1074/jbc.M505268200 Churchward, 2014, Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms, Mol. Brain, 7, 85, 10.1186/s13041-014-0085-7 Lee, 2012, Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels, J. Biol. Chem., 287, 2032, 10.1074/jbc.M111.295451 A-Gonzalez, 2009, Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR, Immunity, 31, 245, 10.1016/j.immuni.2009.06.018 Savage, 2015, Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease, J. Neurosci., 35, 6532, 10.1523/JNEUROSCI.4586-14.2015 Tan, 2012, Anxiety in liver X receptor β knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex, Proc. Natl Acad. Sci. U.S.A., 109, 7493, 10.1073/pnas.1205189109 Yang, 2014, Activation of liver X receptor is protective against ethanol-induced developmental impairment of Bergmann glia and Purkinje neurons in the mouse cerebellum, Mol. Neurobiol., 49, 176, 10.1007/s12035-013-8510-y Namjoshi, 2013, The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E, PLoS One, 8, e53529, 10.1371/journal.pone.0053529 Morales, 2008, Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke, Circulation, 118, 1450, 10.1161/CIRCULATIONAHA.108.782300 Sironi, 2008, Treatment with LXR agonists after focal cerebral ischemia prevents brain damage, FEBS Lett., 582, 3396, 10.1016/j.febslet.2008.08.035 Bigini, 2010, Neuropathologic and biochemical changes during disease progression in liver X receptor β−/− mice, a model of adult neuron disease, J. Neuropathol. Exp. Neurol., 69, 593, 10.1097/NEN.0b013e3181df20e1 Zelcer, 2007, Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors, Proc. Natl Acad. Sci. U.S.A., 104, 10601, 10.1073/pnas.0701096104 Koldamova, 2010, The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration, Biochim. Biophys. Acta, 1801, 824, 10.1016/j.bbalip.2010.02.010 Terwel, 2011, Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis, J. Neurosci., 31, 7049, 10.1523/JNEUROSCI.6546-10.2011 Yu, 2012, Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ), J. Biol. Chem., 287, 42195, 10.1074/jbc.M112.410381 Mounier, 2015, Bexarotene-activated retinoid X receptors regulate neuronal differentiation and dendritic complexity, J. Neurosci., 35, 11862, 10.1523/JNEUROSCI.1001-15.2015 Quintanilla, 2014, Role of PPAR γ in the differentiation and function of neurons, PPAR Res., 2014, 768594, 10.1155/2014/768594 Theofilopoulos, 2015, Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration, F1000Prime Rep., 7, 37, 10.12703/P7-37 Tachibana, 2016, Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1, Exp. Neurol., 277, 1, 10.1016/j.expneurol.2015.12.003 Sandoval-Hernández, 2015, Role of liver X receptor in AD pathophysiology, PLoS One, 10, e0145467, 10.1371/journal.pone.0145467 Sandoval-Hernández, 2016, Liver X receptor agonist modifies the DNA methylation profile of synapse and neurogenesis-related genes in the triple transgenic mouse model of Alzheimer's disease, J. Mol. Neurosci., 58, 243, 10.1007/s12031-015-0665-8 Cui, 2012, Liver X receptor activation attenuates inflammatory response and protects cholinergic neurons in APP/PS1 transgenic mice, Neuroscience, 210, 200, 10.1016/j.neuroscience.2012.02.047 Dai, 2012, Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease, Proc. Natl Acad. Sci. U.S.A., 109, 13112, 10.1073/pnas.1210833109 Cheng, 2008, Regulation of α-synuclein expression by liver X receptor ligands in vitro, Neuroreport, 19, 1685, 10.1097/WNR.0b013e32831578b2 Marwarha, 2011, The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors – relevance to Parkinson's disease, J. Neurochem., 119, 1119, 10.1111/j.1471-4159.2011.07497.x Leoni, 2015, The impairment of cholesterol metabolism in Huntington disease, Biochim. Biophys. Acta, 1851, 1095, 10.1016/j.bbalip.2014.12.018 Boussicault, 2016, CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease, Brain, 139, 953, 10.1093/brain/awv384 Shafaati, 2011, Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo, J. Intern. Med., 270, 377, 10.1111/j.1365-2796.2011.02389.x Russell, 2009, Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain, Annu. Rev. Biochem., 78, 1017, 10.1146/annurev.biochem.78.072407.103859 Futter, 2009, Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors, J. Med. Genet., 46, 438, 10.1136/jmg.2009.066399 Skerrett, 2015, Combined liver X receptor/peroxisome proliferator-activated receptor γ agonist treatment reduces amyloid β levels and improves behavior in amyloid precursor protein/presenilin 1 mice, J. Biol. Chem., 290, 21591, 10.1074/jbc.M115.652008